Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Park Lane Ventures, also known as Park Lane Health Ventures, is a healthcare-focused venture capital and growth equity firm founded in 2014-2015 by Immanuel Thangaraj. The firm emerged as a spinout from Essex Woodlands, one of the largest healthcare-dedicated VC firms globally, which raised $2.4 billion across six funds during Thangaraj's tenure. Park Lane Ventures operates from its offices in Palo Alto and New York City, focusing on later-stage ventures and growth opportunities within the healthcare sector.
The firm leverages the extensive experience and credibility of its founding team to identify and support innovative companies poised to make significant impacts in healthcare. Park Lane Ventures has established itself as a key player in the healthcare investment space, drawing on the strong legacy and expertise inherited from Essex Woodlands.
Park Lane Ventures specializes in later-stage venture and growth equity investments, primarily within the healthcare sector. The firm targets various sub-sectors, including healthcare, biotech, medical devices, health platforms, pharma-tech, and diagnostics. Investment stages include Series A, Series B, Series C, and growth equity, allowing the firm to engage with companies at different points in their development.
Park Lane Ventures aims to identify and support innovative companies that can significantly impact healthcare. The firm looks for founders with a strong vision and the ability to execute their plans effectively. By leveraging the strong pedigree from Essex Woodlands, Park Lane Ventures seeks to provide strategic guidance and industry connections to its portfolio companies.
Park Lane Ventures has a notable portfolio company, Olympic Ophthalmics, which focuses on non-invasive glaucoma treatment devices. Immanuel Thangaraj serves as co-founder and board member of Olympic Ophthalmics, highlighting his active involvement in the company. This investment reflects the firm's commitment to supporting innovative healthcare solutions.
Currently, Olympic Ophthalmics stands as the sole portfolio company mentioned, indicating a focused investment strategy within the healthcare sector. The firm's emphasis on later-stage ventures allows it to concentrate resources and expertise on companies that are poised for growth and impactful contributions to healthcare.
Immanuel Thangaraj — Founder & Managing Director; previously Managing Director at Essex Woodlands (1996-2015), where he raised six funds totaling $2.4 billion. He holds an MBA from the University of Chicago Booth School and has received the Distinguished Alumni Award. Thangaraj is also a co-founder and board member of Olympic Ophthalmics.
Jim Levy — Chairman; no additional details provided regarding his background or previous roles.
As of the latest updates, no specific recent deals or announcements have been found in public sources regarding Park Lane Ventures. However, Immanuel Thangaraj's active role as co-founder and board member of Olympic Ophthalmics indicates ongoing engagement in the healthcare investment space.
What are Park Lane Ventures' investment criteria?
Park Lane Ventures focuses on later-stage venture and growth equity investments in the healthcare sector. The firm seeks innovative companies across various sub-sectors, including biotech, medical devices, and health platforms. They look for strong founding teams with a clear vision and the capability to execute their business plans effectively.
How can founders pitch to Park Lane Ventures?
Founders interested in pitching to Park Lane Ventures should prepare a comprehensive presentation that outlines their business model, market opportunity, and team qualifications. While specific application channels are not disclosed, a warm introduction through industry connections may enhance the chances of engagement.
What makes Park Lane Ventures different from other VC firms?
Park Lane Ventures distinguishes itself through its strong legacy from Essex Woodlands, which has a proven track record in healthcare investments. The firm's focus on later-stage ventures allows it to provide strategic guidance and leverage industry expertise effectively.
What is the geographic scope of Park Lane Ventures?
The firm operates primarily in the United States, with offices located in Palo Alto and New York City. This geographic focus enables Park Lane Ventures to engage closely with innovative healthcare companies in key markets.
What is the typical check size for investments?
While specific check sizes are not disclosed, Park Lane Ventures invests in later-stage rounds, which typically involve larger capital commitments compared to early-stage investments. This allows the firm to support companies as they scale and grow.
What kind of post-investment involvement does Park Lane Ventures have?
Park Lane Ventures adds value to its portfolio companies through strategic guidance, leveraging industry expertise, and facilitating connections within the healthcare ecosystem. The firm's team has extensive backgrounds in the sector, enabling them to provide meaningful support to their investments.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.